Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals.

Öksüz, Zehra; Gragnani, Laura; Lorini, Serena; Temel, Gülhan Örekici; Serin, Mehmet Sami; Zignego, Anna Linda

Öksüz, Zehra; Gragnani, Laura; Lorini, Serena; Temel, Gülhan Örekici; Serin, Mehmet Sami; Zignego, Anna Linda.

Affiliation

Öksüz Z; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, 33160 Mersin, Turkey.
Gragnani L; MASVE Interdepartmental Hepatology Center, Department of Experimental and Clinical Medicine, University of Florence, Center for Research and Innovation CRIA-MASVE, AOU Careggi, 50134 Firenze, Italy.
Lorini S; Department of Translational Research & New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Temel GÖ; MASVE Interdepartmental Hepatology Center, Department of Experimental and Clinical Medicine, University of Florence, Center for Research and Innovation CRIA-MASVE, AOU Careggi, 50134 Firenze, Italy.
Serin MS; Department of Biostatistics, Faculty of Medicine, Mersin University, 33343 Mersin, Turkey.
Zignego AL; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, 33160 Mersin, Turkey.

J Pers Med ; 13(8)2023 Jul 26.

Article de En | MEDLINE | ID: mdl-37623439

Mots clés

direct-acting antivirals; hepatitis C virus; miR-17-5p; miR-223-3p; miR-24-3p

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Pers Med Année: 2023 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google